Legal Opinion
ASTRAZENECA LP v. State
Supreme Court of Alabama
Decided October 16, 2009No. 1071439, 1071440, 1071704, and 1071759PublishedCited by 16 opinions
1Opinion of the Court
*18WOODALL, Justice.
AstraZeneca LP and AstraZeneca Pharmaceuticals LP (hereinafter referred to jointly as “AstraZeneca”);1 SmithKline Beecham Corporation d/b/a GlaxoSmithK-line (“GSK”); and Novartis Pharmaceuticals Corporation (“Novartis”) appeal from judgments entered on jury verdicts in favor of the State of Alabama in actions alleging that AstraZeneca, GSK, and Novartis fraudulently inflated the prices of their prescription drugs for purposes of reimbursement by the Alabama Medicaid Agency (“the AMA”). We reverse the trial court’s judgments and render judgments for AstraZeneca, GSK, and…
2Cases cited21 opinions
- West v. Founders Life Assur. Co. of FloridaSupreme Court of Alabama · 1989
- Harris v. McRaeSupreme Court of the United States · 1980
- Foremost Ins. Co. v. ParhamSupreme Court of Alabama · 1997
- Arkansas Department of Health & Human Services v. AhlbornSupreme Court of the United States · 2006
- Liberty National Life Insurance Company v. WeldonSupreme Court of Alabama · 1957
16 more not listed; retrieve them via the Exa API.
3Cited by16 opinions
- Mississippi Medicaid Pharmaceutical Average Wholesale Price Litigation v. StateMississippi Supreme Court · 2015
- State v. Abbott LaboratoriesWisconsin Supreme Court · 2012
- Hillery v. Allstate Indemnity Co.District Court, S.D. Alabama · 2010
- Sandoz, Inc. v. StateSupreme Court of Alabama · 2012
- Commonwealth v. TAP Pharmaceutical Products, Inc.Supreme Court of Pennsylvania · 2014
11 more not listed; retrieve them via the Exa API.